UBS analyst Chen Chen upgraded Wuxi Biologics (2269:HK) (OTC: WXXWY) from Neutral to Buy with a price target of HK$41.20 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE